| Date | Speaker | Title | Time starts | Duration |
| November 2015 | Chris Kosmidis | Isavuconazole: a new antifungal drug | 0’00’00secs | 0’36’40secs |
| Graham Atherton | Patients and carers disucssion | 0’36’40secs | end | |
| Led by Graham Atherton | Entire meeting (alternate version) |
We had to switch off the discussion with patients after Chris & Graham’s introduction ending at 36min 40sec as the group had to proceed privately. The slides discussed give a good deal of the information we talked about so are well worth reading once the talking has stopped.
Resources mentioned:
Share this post
Latest News posts
Awareness of lung cancer risk in people with COPD
February 28, 2019
Pulmonary Rehabilitation – is it worth it?
February 28, 2019
Patient stories from World Aspergillosis Day
February 22, 2019
Air Pollution Worldwide – Check your town
February 15, 2019
Functional medicine: treating depression
February 15, 2019
Beautiful Cure: Harnessing your body’s natural defences
February 15, 2019
Stay Active to Stay Young
February 15, 2019
Helping People Who Are Socially Isolated Using a Robot
February 15, 2019
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video